Company expects to reach an estimated total of 25 new client
signings in 2024, representing an approximate 35% growth in client
base compared to 2023
NEW
YORK, Nov. 21, 2024 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced today the signing of four
contracts with self-insured employers that are expected to go live
in the first quarter of 2025.
Dario has added four new employer contracts to the 2025 book of
business, continuing the business momentum in the
Business-to-Business-to-Consumer (B2B2C) channel and securing
recurring revenue from these accounts starting in the first quarter
of 2025. The contracts span across the full suite of the Dario
platform, with no one opting for a single condition, showing
evidence of the value of a multi-condition offering.
"We believe that employer contracts are a solid contributor to
near-term growth for Dario. Each one adds recurring revenue, aids
gross margin growth, and spreads our reach across new populations
of users, adding to our ever-growing data pool. Including these
four new employers, we expect to reach an estimated total of 25 new
client signings in 2024, which are expected to be implemented and
secured for revenue growth in 2025. This represents an approximate
35% growth in our client base compared to 2023, a milestone that we
believe serves as a core indicator of our profitability timeline,"
said Steven Nelson, Chief Commercial
Officer at Dario.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the expected timing of the launch of the four
contracts, that the new contracts will continue business momentum
in the B2B2C channel and secure recurring revenue from these
accounts starting January 1st, 2025,
that the employer contracts will contribute to the to near-term
growth of the Company, aid gross margin growth, and spread its
reach across new populations of users, adding to its data
pool, that the Company expects to reach an estimated total of
25 new client signings by the end of 2024 to be implemented and
secured for revenue growth in 2025, and the belief that the
increase in contracts serves as a core indicator of its
profitability timeline . Without limiting the generality of
the foregoing, words such as "plan," "project," "potential,"
"seek," "may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat
Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dario-signs-four-new-employer-contracts-across-full-product-suite-302312980.html
SOURCE DarioHealth Corp.
